RMD

MKT CAP:$27B

ResMed Inc

Market Cap

$27B

Healthcare·Medical Instruments & Supplies·🇺🇸 United States·NYSE

Healthcare·Medical·🇺🇸·NYSE

Stock Price

$193.14-$50.38 (-20.69%)

Jun 8, 2026

52W High $291.4952W Low $182.82

Company Details

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two se...

CEO

—

IPO Date

Jun 2, 1995

Website

www.resmed.com

Key Metrics TTM

Revenue

$5.5B

+10.3% YoY

Net Income

$1.5B

EPS (Diluted)

Free Cash Flow

$1.8B

Revenue / Share

$37.66

Gross Margin

61.7%

Operating Margin

34.3%

Net Margin

27.4%

FCF Margin

31.7%

P/S

4.9x

P/E

17.8x

Earnings Reports

Q4 2026

Aug 6, 2026

PENDING

Q3 2026

Apr 30, 2026

$1.4B+10.8%

Q2 2026

Jan 30, 2026

$1.4B+11.0%

Q1 2026

Oct 31, 2025

$1.3B+9.1%

FY 2025

Aug 8, 2025

$5.1B+9.8%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee